0001654954-22-009457.txt : 20220708
0001654954-22-009457.hdr.sgml : 20220708
20220708161026
ACCESSION NUMBER: 0001654954-22-009457
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220707
FILED AS OF DATE: 20220708
DATE AS OF CHANGE: 20220708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandler Andrew Seth
CENTRAL INDEX KEY: 0001596060
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40739
FILM NUMBER: 221074514
MAIL ADDRESS:
STREET 1: 1301 2ND AVE
CITY: SEATTLE
STATE: WA
ZIP: 98101
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dermata Therapeutics, Inc.
CENTRAL INDEX KEY: 0001853816
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858)-223-0882
MAIL ADDRESS:
STREET 1: 3525 DEL MAR HEIGHTS RD., #322
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
section16.xml
FORM 4
X0306
4
2022-07-07
0001853816
Dermata Therapeutics, Inc.
DRMA
0001596060
Sandler Andrew Seth
3525 DEL MAR HEIGHTS RD.
#322
SAN DIEGO
CA
92130
true
Common Stock, par value $0.0001 per share
2022-07-07
4
A
false
8874
0
A
14064
D
On July 7, 2022, the Reporting Person was granted 8,874 Common Stock restricted units pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan.
/s/ Gerald T. Proehl, Attorney-in-Fact
2022-07-08